Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
RBCPF
- Development stage
- Discontinued
- Lead developer
- Targeted Medical Pharma
- Modality
- Small Molecules
01
Overview
**RBCPF** is an investigational amino-acid-based red blood cell precursor formulation developed by Targeted Medical Pharma for mild to moderate anemia. It was evaluated in an open-label pilot study designed to measure changes in hemoglobin following administration. The formulation was described in the trial record as a medical-food-type amino acid preparation intended to support red blood cell and hemoglobin production; its precise ingredient composition, dosage form, route of administration, and molecular targets were not publicly specified. The registered Phase 2/3 study was withdrawn.
- Other names
- Red blood cell precursor formulation
Beyond the preview
Go deeper on RBCPF.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RBCPF.